François Malecaze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
François Malecaze has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Jean-Louis Arné
2 shared publicationsPierre Fournié
Department of Ophthalmology Purpan Hospital, Toulouse, France
2 shared publicationsStéphane D. Galiacy
Department of Ophthalmology Purpan Hospital, Toulouse, France 2Laboratory of Pathology, Purpan Hospital, Toulouse, France 3Department of Biochemistry, Rangueil Hospital, Toulouse, France 4Department of Ophthalmology, Technische Universität Dresden, Dresde
2 shared publicationsVincent Soler
Department of Ophthalmology Purpan Hospital, Toulouse, France 2Laboratory of Pathology, Purpan Hospital, Toulouse, France 3Department of Biochemistry, Rangueil Hospital, Toulouse, France 4Department of Ophthalmology, Technische Universität Dresden, Dresde
2 shared publicationsA Decha
INSERM U563, Department Ophtalmologie et Pathologie des épithéliums, Hôpital Purpan, Toulouse, France
1 shared publication- Alain Hovnanian
INSERM UMR 1163, Laboratory of genetic skin diseases, Imagine Institute of Genetic Diseases, University Paris Cité and Department of Genomic Medicine of Rare Diseases, AP-HP, Hôpital Necker-Enfants Malades, Paris, France
1 shared publication
Latest Publications
- Open Access
- 1 February 2016
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 57 (2) , 594-603
Iontophoresis Transcorneal Delivery Technique for Transepithelial Corneal Collagen Crosslinking With Riboflavin in a Rabbit Model
Purpose To compare an iontophoresis riboflavin delivery technique for transepithelial corneal collagen crosslinking (I-CXL) with a conventional CXL (C-CXL). Methods We designed 3 experimental sets using 152 New Zealand rabbits to study riboflavin application by iontophoresis using charged riboflavin solution (Ricrolin+®) with a 1mA current for 5 min. The first set was to compare riboflavin concentration measured by High-Performance Liquid Chromatography (HPLC) in corneas after iontophoresis or conventional riboflavin application. The second set was to analyze autofluorescence and stromal collagen modification immediately and 14 days after I-CXL or C-CXL, by using nonlinear two-photon microscopy (TP) and second harmonic generation (SHG). In the third set, physical modifications after I-CXL and C-CXL were evaluated by stress-strain measurements and by studying corneal resistance against collagenase digestion. Results Based on HPLC analysis, we found that iontophoresis allowed riboflavin diffusion with two-fold less riboflavin concentration than conventional application (936.2 ± 312.5 ng/ml and 1708 ± 908.3 ng/ml, respectively, p<0.05). Corneal TP and SHG imaging revealed that I-CXL and C-CXL resulted in a comparable increased anterior and median stromal autofluorescence and collagen packing. The stress at 10% strain showed a similar stiffness of corneas treated by I-CXL or C-CXL (631.9 ±241.5 kPa and 680.3 ±216.4 kPa, respectively, p=0.908). Moreover, we observed an increased resistance against corneal collagenase digestion after I-CXL and C-CXL (61.90 ±5.28 % and 72.21 ±4.32 % of remaining surface, respectively, p=0.154). Conclusions This experimental study suggests that I-CXL is a promising alternative methodology for riboflavin delivery in crosslinking treatments, preserving the epithelium.
- 1 February 2016
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 57 (2) , 594-603
Open AccessIontophoresis Transcorneal Delivery Technique for Transepithelial Corneal Collagen Crosslinking With Riboflavin in a Rabbit Model
Purpose To compare an iontophoresis riboflavin delivery technique for transepithelial corneal collagen crosslinking (I-CXL) with a conventional CXL (C-CXL). Methods We designed 3 experimental sets using 152 New Zealand rabbits to study riboflavin application by iontophoresis using charged riboflavin solution (Ricrolin+®) with a 1mA current for 5 min. The first set was to compare riboflavin concentration measured by High-Performance Liquid Chromatography (HPLC) in corneas after iontophoresis or conventional riboflavin application. The second set was to analyze autofluorescence and stromal collagen modification immediately and 14 days after I-CXL or C-CXL, by using nonlinear two-photon microscopy (TP) and second harmonic generation (SHG). In the third set, physical modifications after I-CXL and C-CXL were evaluated by stress-strain measurements and by studying corneal resistance against collagenase digestion. Results Based on HPLC analysis, we found that iontophoresis allowed riboflavin diffusion with two-fold less riboflavin concentration than conventional application (936.2 ± 312.5 ng/ml and 1708 ± 908.3 ng/ml, respectively, p<0.05). Corneal TP and SHG imaging revealed that I-CXL and C-CXL resulted in a comparable increased anterior and median stromal autofluorescence and collagen packing. The stress at 10% strain showed a similar stiffness of corneas treated by I-CXL or C-CXL (631.9 ±241.5 kPa and 680.3 ±216.4 kPa, respectively, p=0.908). Moreover, we observed an increased resistance against corneal collagenase digestion after I-CXL and C-CXL (61.90 ±5.28 % and 72.21 ±4.32 % of remaining surface, respectively, p=0.154). Conclusions This experimental study suggests that I-CXL is a promising alternative methodology for riboflavin delivery in crosslinking treatments, preserving the epithelium.
- 1 December 2012
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 53 (13) , 7983-7988
A Genome-Wide Association Study Provides Evidence for Association of Chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with High Myopia in the French Population
Purpose.: Myopia is a complex trait affected by both genetic and environmental factors. High myopia is associated with increased risk of sight threatening eye disorders such as retinal detachment. The purpose of this genome-wide association study was to identify susceptibility genes contributing to high myopia in the French population. Methods.: High myopic cases were genotyped using Affymetrix SNP 6.0 chips and population controls were selected from the GABRIEL French dataset, in which samples were genotyped by Illumina Human610 quad array. The association study was conducted using 152,234 single nucleotide polymorphisms that were present on both manufacturers' chips in 192 high myopic cases and 1064 controls to identify associated regions. Imputation was performed on peak regions. Results.: Associations were found at known myopia locus MYP10 on chromosome 8p23 and MYP15 on chromosome 10q21.1. Rs189798 (8p23), and rs10825992 (10q21.1) showed the strongest associations in these regions (P = 6.32 × 10−7 and P = 2.17 × 10−5, respectively). The imputed results at 8p23 showed two peaks of interest. The first spanned 30 kb including rs189798 between MIR4660 and PPP1R3B with the most significant association at rs17155227 (P = 1.07 × 10−10). The second novel peak was 4 kb in length, encompassing MIR124-1 and the MSRA gene, with the strongest association at rs55864141 (P = 1.30 × 10−7). The peak of imputed data at 10q21.1 was 70 kb in length between ZWINT and MIR3924, with rs3107503 having the lowest P value (P = 1.54 × 10−7). Conclusions.: We provide evidence for the association of MYP10 at 8p23 and MYP15 at 10p21.1 with high myopia in the French population and refine these regions of association.
- 1 December 2012
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 53 (13) , 7983-7988
A Genome-Wide Association Study Provides Evidence for Association of Chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with High Myopia in the French Population
Purpose.: Myopia is a complex trait affected by both genetic and environmental factors. High myopia is associated with increased risk of sight threatening eye disorders such as retinal detachment. The purpose of this genome-wide association study was to identify susceptibility genes contributing to high myopia in the French population. Methods.: High myopic cases were genotyped using Affymetrix SNP 6.0 chips and population controls were selected from the GABRIEL French dataset, in which samples were genotyped by Illumina Human610 quad array. The association study was conducted using 152,234 single nucleotide polymorphisms that were present on both manufacturers' chips in 192 high myopic cases and 1064 controls to identify associated regions. Imputation was performed on peak regions. Results.: Associations were found at known myopia locus MYP10 on chromosome 8p23 and MYP15 on chromosome 10q21.1. Rs189798 (8p23), and rs10825992 (10q21.1) showed the strongest associations in these regions (P = 6.32 × 10−7 and P = 2.17 × 10−5, respectively). The imputed results at 8p23 showed two peaks of interest. The first spanned 30 kb including rs189798 between MIR4660 and PPP1R3B with the most significant association at rs17155227 (P = 1.07 × 10−10). The second novel peak was 4 kb in length, encompassing MIR124-1 and the MSRA gene, with the strongest association at rs55864141 (P = 1.30 × 10−7). The peak of imputed data at 10q21.1 was 70 kb in length between ZWINT and MIR3924, with rs3107503 having the lowest P value (P = 1.54 × 10−7). Conclusions.: We provide evidence for the association of MYP10 at 8p23 and MYP15 at 10p21.1 with high myopia in the French population and refine these regions of association.
- 1 August 2012
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 38 (8) , 1515
Reply : Crosslinking and toric phakic IOL in keratoconus
- 1 August 2012
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 38 (8) , 1515
Reply : Crosslinking and toric phakic IOL in keratoconus
- 1 December 2011
- Published by Elsevier in Journal of Proteomics
- Vol. 75 (1) , 81-92
Deeper in the human cornea proteome using nanoLC–Orbitrap MS/MS: An improvement for future studies on cornea homeostasis and pathophysiology
- 1 December 2011
- Published by Elsevier in Journal of Proteomics
- Vol. 75 (1) , 81-92
Deeper in the human cornea proteome using nanoLC–Orbitrap MS/MS: An improvement for future studies on cornea homeostasis and pathophysiology
- 31 October 2007
- Published by Elsevier in Ophthalmology
- Vol. 114 (10) , 1839-1841
Late-Onset Hyaloideocapsular Block Syndrome
- 31 October 2007
- Published by Elsevier in Ophthalmology
- Vol. 114 (10) , 1839-1841
Late-Onset Hyaloideocapsular Block Syndrome
- 1 May 2006
- Published by Elsevier in Ophthalmology
- Vol. 113 (5) , 742-746
Corneal Ectasia after Photorefractive Keratectomy for Low Myopia
- 1 May 2006
- Published by Elsevier in Ophthalmology
- Vol. 113 (5) , 742-746
Corneal Ectasia after Photorefractive Keratectomy for Low Myopia
- 27 October 2005
- Published by Springer Nature in Gene Therapy
- Vol. 13 (5) , 440-448
Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells
Posterior capsule opacification (PCO) is a common complication of cataract surgery. Using adenovirus(Ad)-mediated gene transfer, we overexpressed the proapoptotic molecules p53, procaspase 3, Bax, and TRAIL to induce therapeutic programmed cell death of residual lens cells to prevent PCO. Overexpressed TRAIL did not induce apoptosis in cultured rabbit lens cells or in human lens cells. Overexpressed p53 induced apoptosis of lens cells in vitro and ex vivo, but was unable to prevent PCO in vivo. Overexpressed procaspase 3 was associated with engagement of many components of the apoptotic pathway, including cleavage of intracellular caspase targets such as PARP and inter-nucleosome DNA fragmentation. Even when only slightly overexpressed, Bax caused apoptosis of transduced rabbit and human lens cells by engaging the mitochondrial pathway, including catalytic activation of the caspases. A single in vivo injection of Ad vectors expressing either Bax or procaspase 3 into the capsular bag at the end of phacoemulsification prevented PCO in rabbits. These experiments show that Ad-mediated Bax or procaspase 3 overexpression is capable of inducing therapeutic programmed cell death in vitro and in vivo in residual lens cells and preventing PCO in a rabbit model of PCO. Manipulation of proapoptotic molecule expression could be a novel gene therapy approach for prevention of PCO.
- 27 October 2005
- Published by Springer Nature in Gene Therapy
- Vol. 13 (5) , 440-448
Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells
Posterior capsule opacification (PCO) is a common complication of cataract surgery. Using adenovirus(Ad)-mediated gene transfer, we overexpressed the proapoptotic molecules p53, procaspase 3, Bax, and TRAIL to induce therapeutic programmed cell death of residual lens cells to prevent PCO. Overexpressed TRAIL did not induce apoptosis in cultured rabbit lens cells or in human lens cells. Overexpressed p53 induced apoptosis of lens cells in vitro and ex vivo, but was unable to prevent PCO in vivo. Overexpressed procaspase 3 was associated with engagement of many components of the apoptotic pathway, including cleavage of intracellular caspase targets such as PARP and inter-nucleosome DNA fragmentation. Even when only slightly overexpressed, Bax caused apoptosis of transduced rabbit and human lens cells by engaging the mitochondrial pathway, including catalytic activation of the caspases. A single in vivo injection of Ad vectors expressing either Bax or procaspase 3 into the capsular bag at the end of phacoemulsification prevented PCO in rabbits. These experiments show that Ad-mediated Bax or procaspase 3 overexpression is capable of inducing therapeutic programmed cell death in vitro and in vivo in residual lens cells and preventing PCO in a rabbit model of PCO. Manipulation of proapoptotic molecule expression could be a novel gene therapy approach for prevention of PCO.
- Open Access
- 1 January 2005
- Published by BMJ in Journal of Medical Genetics
- Vol. 42 (1) , 88-94
Identification of a new locus for isolated familial keratoconus at 2p24
The cause of KC is still unknown. Histological observations have demonstrated degradation of the corneal epithelium basal membrane, diminution of the number of collagen fibrils, thinning of the corneal stroma, and keratocyte apoptosis.2, 3 Biochemical studies describe increased activity of metalloproteinases (MMP-2 and MMP-9) and lower expression of protease inhibitors such as α1-protease inhibitor.4, 5
- 1 January 2005
- Published by BMJ in Journal of Medical Genetics
- Vol. 42 (1) , 88-94
Open AccessIdentification of a new locus for isolated familial keratoconus at 2p24
The cause of KC is still unknown. Histological observations have demonstrated degradation of the corneal epithelium basal membrane, diminution of the number of collagen fibrils, thinning of the corneal stroma, and keratocyte apoptosis.2, 3 Biochemical studies describe increased activity of metalloproteinases (MMP-2 and MMP-9) and lower expression of protease inhibitors such as α1-protease inhibitor.4, 5
- 1 September 2002
- Published by Elsevier in Ophthalmology
- Vol. 109 (9) , 1622-1630
A randomized paired eye comparison of two techniques for treating moderately high myopia LASIK and artisan phakic lens
- 1 September 2002
- Published by Elsevier in Ophthalmology
- Vol. 109 (9) , 1622-1630
A randomized paired eye comparison of two techniques for treating moderately high myopia LASIK and artisan phakic lens
- 1 December 2001
- Published by Elsevier in Ophthalmology
- Vol. 108 (12) , 2213-2218
Abnormal activation in the visual cortex after corneal refractive surgery for myopia Demonstration by functional magnetic resonance imaging
- 1 December 2001
- Published by Elsevier in Ophthalmology
- Vol. 108 (12) , 2213-2218
Abnormal activation in the visual cortex after corneal refractive surgery for myopia Demonstration by functional magnetic resonance imaging